Advertisement

Topics

NICE issues draft guidance on Almirall’s Skilarence for psoriasis

07:45 EDT 4 Aug 2017 | thePharmaLetter

The National Institute for Health and Care Excellence (NICE), the cost-effectiveness watchdog for England…

Original Article: NICE issues draft guidance on Almirall’s Skilarence for psoriasis

NEXT ARTICLE

More From BioPortfolio on "NICE issues draft guidance on Almirall’s Skilarence for psoriasis"

Quick Search
Advertisement
 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...